Official Coronavirus Yellow Card Reporting Data

 

Click the link below to visit Official Government Coronavirus Yellow Card Report.
https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting

The Information quoted below has been copied directly from sections of the above government website. Please refer to the link above for the rest of the report in its entirety.

 

Adverse Reactions
 

"As of 30 March 2022, for the UK, 168,462 Yellow Cards have been reported for the COVID-19 Pfizer/BioNTech Vaccine, 244,525 have been reported for the COVID-19 Vaccine AstraZeneca, 36,682 for the COVID-19 Vaccine Moderna and 1,608 have been reported where the brand of the vaccine was not specified."

TOTAL UK YELLOW CARDS = 451,277 Yellow Card reports - Up to 30th March 2022

"In the 7 days since the previous summary for 23 March 2022 we have received a further 434 Yellow Cards for the COVID-19 Pfizer/BioNTech Vaccine, 110 for the COVID-19 Vaccine AstraZeneca, 152 for the COVID-19 Vaccine Moderna and 14 where the brand was not specified."
​​

TOTAL UK YELLOW CARDS IN 7 DAYS = 710 Yellow Card reports - From the 23 March to 30 March 2022

"Up to and including 30 March 2022, the MHRA received and analysed 244,525 UK Yellow Cards from people who have received the COVID-19 Pfizer/BioNTech Vaccine. These reports include a total of 484,407 suspected reactions (i.e. a single report may contain more than one symptom). The first report was received on 9 December 2020.

Up to and including 30 March 2022, the MHRA received and analysed a total of 244,525 UK reports of suspected ADRs to the COVID-19 Vaccine AstraZeneca. These reports include a total of 865,933 suspected reactions (a single report may contain more than one symptom). The first report was received on 4 January 2021.

Up to and including 30 March 2022, the MHRA received and analysed a total of 36,682 UK reports of suspected ADRs to the COVID-19 Vaccine Moderna. These include a total 122,095 suspected reactions (a single report may contain more than one symptom). The first report was received on 7 April 2021.

Additionally, up to and including 9 March 2022, the MHRA received 1,608 Yellow Card reports where the brand of vaccine was not specified by the reporter."

Miscarriage and Stillbirths

"A few reports of commonly occurring congenital anomalies and obstetric events have also been received."
 

"Although, like most vaccines and medicines, clinical trials of COVID-19 vaccines in pregnant women were not carried out prior to use of the vaccines in the general population."

Breastfeeding

"We have received about 4,000 Yellow Card reports from women breastfeeding at the time of vaccination."

"A small number of women have reported decreases in their milk supply, most of which were transient, or possible reactions in their breastfed child"

"A small number of women may experience a reduction in their breast milk production and it may be helpful for breastfeeding women to know how to maintain their breast milk supply, particularly if they are feeling unwell. The NHS website has a good resource for this."

Under 18

"The MHRA has received 3,391 UK reports of suspected ADRs for the COVID-19 Pfizer/BioNTech Vaccine in which the individual was reported to be under 18 years old, 262 reports for the COVID-19 Vaccine AstraZeneca, 24 for the COVID-19 Vaccine Moderna and 23 where the brand of vaccine was unspecified."
TOTAL = 3,700 Adverse Reactions - Up to the 30 March 2022

"There has been a small number of reports for myocarditis and pericarditis (inflammation of the heart) in individuals under 18 years both in the UK and internationally. This is a recognised potential risk with the COVID-19 Pfizer/BioNTech Vaccine and COVID-19 Vaccine Moderna and the MHRA is closely monitoring these events."

Boosters


"Up to the 30 March 2022 the MHRA has received 30,497 UK reports of suspected ADRs where the COVID-19 Pfizer/BioNTech Vaccine was reported to be the booster dose, 503 reports where the COVID-19 Vaccine AstraZeneca was reported to be the booster dose, 16,504 reports where the COVID-19 Vaccine Moderna was reported to be the booster dose and 168 reports where the brand of vaccine booster was unspecified."
TOTAL = 47,688 Adverse Reactions
- Up to 30th March 2022

"There have been a small number of reports of suspected myocarditis and pericarditis (inflammation of the heart) following booster doses with Pfizer/BioNTech and Moderna COVID-19 vaccines. This is a recognised potential risk with the COVID-19 Pfizer/BioNTech Vaccine and COVID-19 Vaccine Moderna and the MHRA is closely monitoring these events."

Anaphylaxis

"The MHRA continues to monitor reports of severe allergic reactions with the COVID-19 Pfizer/BioNTech Vaccine and has received 656 UK spontaneous adverse reactions associated with anaphylaxis or anaphylactoid reactions."

Anaphlaxis 

"The MHRA is closely monitoring reports of anaphylaxis with the COVID-19 Vaccine Moderna and has received 87 reports of anaphylaxis in association with the vaccine. Anaphylaxis is a potential side effect of the vaccine, and it is recommended that those with known hypersensitivity to the ingredients of the vaccine should not receive it."

"The MHRA also closely monitors reports of anaphylaxis or anaphylactoid reactions with the COVID-19 Vaccine AstraZeneca and has received 881 UK spontaneous adverse reactions associated with anaphylaxis or anaphylactoid reactions reported and such reports are very rare. The product information reflects the fact that reports of anaphylaxis have been received for the COVID-19 Vaccine AstraZeneca."

TOTAL = 1,624 Adverse Reactions of Anaphylaxis - Up to 30 March 2022

Bell's Palsy

"Bell’s palsy (BP) is temporary weakness or paralysis affecting one side of the face that develops gradually; most people recover from this condition within a few months."

"Reports of suspected BP following COVID-19 vaccination have been continuously reviewed by the MHRA. Whilst reporting of BP following COVID-19 vaccination is rare, evidence based on the latest available data shows that there may be an increased risk of BP following COVID-19 vaccination."

Transverse Myelitis

"As of 30 March 2022, we have received 121 reports of suspected TM following administration of COVID-19 AstraZeneca, 36 reports following administration of COVID-19 Pfizer/BioNTech Vaccine and 3 reports following administration of COVID-19 vaccine Moderna."

TOTAL = 160 Adverse Reactions of Transverse Myelitis - 9 March 2022 - Up to 22

"Due to the serious nature of this adverse event and as a precaution, the product information has been updated to raise healthcare professionals’ and patients’ awareness of the signs and symptoms associated with TM which may include muscle weakness, localised or radiating back pain, bladder and bowel symptoms and changes in sensation. It is recommended that patients who had an episode of transverse myelitis following the first dose of COVID-19 vaccine AstraZeneca should not receive a second dose of this vaccine."

Thrombo-embolic (Blood Clotting) Events

"Anyone who experienced cerebral or other major blood clots occurring with low levels of platelets after their first vaccine dose of COVID-19 Vaccine AstraZeneca should not have further doses."

"Anyone who experiences any of the following from around 4 days after vaccination should seek medical advice urgently:

  • a severe headache that is not relieved with simple painkillers or gets worse or feels worse when you lie down or bend over

  • an unusual headache that may be accompanied by blurred vision, confusion, difficulty with speech, weakness, drowsiness or seizures (fits)

  • rash that looks like small bruises or bleeding under the skin beyond the injection site

  • shortness of breath, chest pain, leg swelling or persistent abdominal (tummy) pain.

"Up to 30 March 2022, the MHRA had received Yellow Card reports of 439 cases of major thromboembolic events (blood clots) with concurrent thrombocytopenia (low platelet counts) in the UK following vaccination with COVID-19 Vaccine AstraZeneca. Forty-nine of the 438 reports have been reported after a second dose. Of the 438 reports, 220 occurred in females, and 214 occurred in males aged from 18 to 93 years. The overall case fatality rate was 18% with 79 deaths, six of which occurred after the second dose."

Cerebral venous sinus thrombosis was reported in 160 cases (average age 46 years) and 279 had other major thromboembolic events (average age 54 years) with concurrent thrombocytopenia."

Up to 30 March 2022, the MHRA had received Yellow Card reports of 32 cases of major thromboembolic events (blood clots) with concurrent thrombocytopenia (low platelet counts) in the UK following use of the COVID-19 Pfizer/BioNTech Vaccine. These events occurred in 13 females, and 18 males aged from 18 to 91 years, and the overall case fatality rate was 13% with four deaths reported.

Up to 30 March 2022, the MHRA had received Yellow Card reports of 6 cases of major thromboembolic events (blood clots) with concurrent thrombocytopenia (low platelet counts) in the UK following the use of COVID-19 vaccine Moderna. The 4 events occurred in adult males under the age of 60, and there have been no fatal cases reported."

Thrombo-embolic (blood clotting) events without concurrent low platelets

"The MHRA has conducted a thorough review of events of cerebral venous sinus thrombosis (CVST) without concurrent low platelet levels following vaccination with the COVID-19 Vaccine AstraZeneca and sought advice from the CHM’s Vaccine Benefit Risk Expert Working Group. Blood clotting events with lowered platelets are described in a separate section (above). The scientific review concluded that there is a possible link between CVST without low platelets and COVID-19 Vaccine AstraZeneca."

Immune Thrombocytopenia

​"Immune thrombocytopenia (ITP) is a condition where the immune system does not function correctly and becomes involved in destroying platelets, which can lead to bleeding; these events are usually short-lived and of minor severity. Reports of ITP following COVID-19 vaccination have been closely monitored by the MHRA."

"Following the most recent review, the available data suggested a possible link between COVID-19 vaccine AstraZeneca and ITP,"

Capillary Leak Syndrome

"The MHRA has received 17 reports of suspected capillary leak syndrome (a condition where fluid leaks from the small blood vessels into the body)"

Menstrual Disorders (Period Problems) and Unexpected Vaginal Bleeding

"Up to 30 March 2022 a total of 50,809 suspected reactions relating to a variety of menstrual disorders have been reported after all three of the COVID-19 vaccines including heavier than usual periods, delayed periods and unexpected vaginal bleeding. These suspected reactions have been reported in 39,591 individual Yellow Card reports (as each report may contain more than one suspected reaction)."

TOTAL - 50,809 Cases of Menstrual Disorders - Up to 30 March 2022

Myocarditis and Pericarditis (Inflammation of the Heart)

"There has been a consistent pattern of higher reporting of these suspected events with the COVID-19 Pfizer/BioNTech and COVID-19 Vaccine Moderna, and of these occurring more frequently in males. In the UK the body of evidence shows that for Pfizer in particular, there is similar frequency of reporting after the first and second dose, with suspected events typically occurring within 7 days after vaccination."

"It is important that anyone who experiences new onset of symptoms such as chest pain, shortness of breath or feelings of having a fast-beating, fluttering, or pounding heart seeks medical attention."

"Up to and including 30 March 2022, we have received 766 reports of myocarditis

and 525 reports of pericarditis following use of the COVID-19 Pfizer/BioNTech Vaccine, as well as ten reports of carditis, four reports for viral myocarditis, three reports each for viral pericarditis and infective pericarditis, two reports each for myocarditis mycotic and endocarditis, and one report each of constrictive pericarditis, pleuropericarditis, lupus pericarditis, non-infective endocarditis, infectious myocarditis, eosinophilic myocarditis, hypersensitivity myocarditis, myocarditis post infection, bacterial myocarditis, septic myocarditis and streptococcal endocarditis. "
TOTAL Pfizer = 1,326 Cases of types of Myocarditis/Pericarditis - Up to 30 March 2022

"For COVID-19 Vaccine AstraZeneca there have been 221 reports of myocarditis and 217 reports of pericarditis following vaccination up to and including 30 March 2022 as well as eight reports for endocarditis, five reports for viral pericarditis, three reports for viral myocarditis, two reports each for bacterial endocarditis, carditis, and acute endocarditis, and one report each for infectious myocarditis, myocarditis post infection and autoimmune myocarditis."

TOTAL AstraZeneca = 463 Cases of Myocarditis/Pericarditis - Up to 30 March 2022

"There have been 211 reports of myocarditis, 122 reports of pericarditis, two reports of carditis and one report each of hypersensitivity myocarditis, pleuropericarditis and endocarditis following use of COVID-19 Vaccine Moderna up to the same date."

TOTAL Moderna = 338 Cases of Myocarditis/Pericarditis - Up to 30 March 2022

"FOUR FATAL events have been reported associated with the COVID-19 Pfizer/BioNTech Vaccine and FOUR FATAL events associated with the COVID-19 Vaccine AstraZeneca. There have been no fatal myocarditis or pericarditis events reported with the COVID-19 Vaccine Moderna to date."

TOTAL 8 DEATHS REPORTED of Myocarditis/Pericarditis - Up to 30 March 2022

"When the reporting rate is calculated by age group (see Table 8) the reporting rate for suspected myocarditis and pericarditis is highest in the 18-29-year age group for the

Pfizer/BioNTech and Moderna COVID-19 vaccines. "

"Two large European epidemiological studies have estimated the excess risk of myocarditis following vaccination with COVID-19 Pfizer/BioNTech Vaccine and COVID-19 Vaccine Moderna. One study showed that in a period of 7 days after the second dose of COVID-19 Pfizer/BioNTech Vaccine there were about 27 (95% CI 26 - 28) extra cases of myocarditis in 12-29 year old males per million compared to unvaccinated individuals, and for COVID-19 vaccine Moderna there were about 132 (95% CI 130 – 133) extra cases of myocarditis in 12-29 year old males per million."

"In another study, in a period of 28 days after the second dose of the COVID-19 Pfizer/BioNTech Vaccine there were 57 [95% CI 39 – 75] extra cases of myocarditis in 16-24 year old males per million compared to unvaccinated persons, and for COVID-19 vaccine Moderna. there were 190 (95% CI 96 – 280) extra cases of myocarditis in 16-24 year old males per million individuals compared to unvaccinated individuals."

Delayed Hypersensitivity Reactions

"The MHRA has been reviewing reports of skin reactions occurring around the vaccination site that appear a little while after vaccination. These reactions are suggestive of a delayed hypersensitivity reaction that occurs 4-11 days after vaccination. The reactions are characterized by a rash, swelling and tenderness that can cover the whole upper arm and may be itchy and/or painful and warm to the touch."

Guillian -Barre Syndrome & Miller Fisher Syndrome

"Guillain-Barré Syndrome is a very rare condition which causes inflammation of the nerves and can lead to numbness, weakness and pain, usually in the feet, hands and limbs and can spread to the chest and face. Guillain-Barré Syndrome tends to affect both sides of the body at once."

"Up to and including the 9 March 2022, the MHRA has received 491 reports of suspected Guillain-Barré Syndrome with the COVID-19 Vaccine AstraZeneca and 29 reports of a related disease called Miller Fisher syndrome. Up to the same date, the MHRA has received 101 reports of Guillain-Barré Syndrome following use of the COVID-19 Pfizer/BioNTech Vaccine and 5 reports of Miller Fisher syndrome and for the COVID-19 Vaccine Moderna there have been 17 reports of Guillain-Barré Syndrome."

TOTAL Yellow Cards Reported = 643 - Up to 30 March 2022

Swelling of the Vaccinated Limb

"There have been rare reports of extensive swelling of the vaccinated limb after receiving the COVID-19 Pfizer/BioNTech Vaccine. The product information has been updated to include “extensive swelling of the vaccinated limb” as a side effect of the vaccine."

Facial swelling in those with a history of facial dermal fillers

"The MHRA has also received Yellow Card reports of facial swelling in those with a history of injection of facial dermal fillers for the COVID-19 Pfizer/BioNTech Vaccine."

Events with a FATAL outcome

"The MHRA has received 744 UK reports of suspected ADRs to the COVID-19 Pfizer/BioNTech Vaccine in which the patient died shortly after vaccination, 1,252 reports for the COVID-19 Vaccine AstraZeneca, 43 for the COVID-19 Vaccine Moderna and 43 where the brand of vaccine was unspecified."

TOTAL OF 2,039 FATALITIES REPORTED  - Up to 30 March 2022

Adult Monthly Breakdown

TOTAL - 451,277 Yellow Cards Reported - As of 30th March 2022

TOTAL - 450,567 Yellow Cards Reported - Reported on 23rd March February 2022

TOTAL - 449,324 Yellow Cards Reported - As of 9th March 2022

TOTAL - 448,616 Yellow Cards Reported - Reported on 2nd March February 2022

TOTAL - 447,795 Yellow Cards Reported - Reported on 23rd February 2022

TOTAL = 446,382 Yellow Cards Reported - Reported on 16 February 2022

Under 18's Monthly Breakdown

TOTAL - 3,700 Yellow Cards Reported - As of 30th March 2022
TOTAL = 3,569 Adverse Reactions Reported - Up to the 9 March 2022

TOTAL = 3,396 Adverse Reactions Reported - Reported on 16 February 2022 

TOTAL = 3,252 Adverse Reactions Reported - Reported on 02 February 2022

Have you suffered from an adverse reaction?

If you have suffered from an adverse reaction after receiving a COVID-19 Vaccine please, as well as logging it with us, make an official report to the government Yellow Card Scheme. Any information which is submitted to us is not associated with the government's Yellow Card Scheme.

To make a report at the government Yellow Card Scheme please click the link below

https://www.coronavirus-yellowcard.mhra.gov.uk

Due to the Yellow Card Scheme being difficult to read and hard to navigate the UK Column have a Yellow Card Scheme and incorporated a search to allow for investigation into individual adverse reactions i.e Blood Disorders. You can find this at the below web address

https://yellowcard.ukcolumn.org/yellow-card-reports

Reporting your injury as a crime

If you was not told about the risks listed before you was given your Covid-19 Vaccine then you could not give full informed consent, as a result of this, you have been a victim of malpractice. 

It has become apparent that the corporations including Big Pharma, Big Tech and the Government have been suppressing vital information about potential dangers from the public some of these doctors include Dr. Mike Yeadon Former Pfizer VP & Chief Scientific Officer, allergy and respiratory R&D , Dr. Geert Vanden Bossche Virologist, Vaccinologist, Ph.D. D.V.M and Dr Peter McCullough. This is a crime, to have been told that a medical procedure is 'safe and effective' and not be completely transparent about the adverse reactions and deaths amounting.

Many people around the UK are reporting their injuries as a crime to their local police station. You can read more about this on the 'Criminal Investigation' Page.

Find out more by joining the Telegram channel 

https://t.me/publicannouncement602967921

Or go straight to the Not On The BeeB website to read more about how you can submit a witness statement to help the vaccine injunction and pause the roll out of the Covid-19 Vaccines.

https://www.notonthebeeb.co.uk

Information presented in a table format

Below is the information which you have previously read presented in a table format. These tables are from the government Yellow

Card scheme.